388 related articles for article (PubMed ID: 27587556)
41. Increased platelet binding to circulating monocytes in idiopathic pulmonary fibrosis.
Fahim A; Crooks MG; Morice AH; Hart SP
Lung; 2014 Apr; 192(2):277-84. PubMed ID: 24395126
[TBL] [Abstract][Full Text] [Related]
42. Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy.
Chen HM; Ma G; Gildener-Leapman N; Eisenstein S; Coakley BA; Ozao J; Mandeli J; Divino C; Schwartz M; Sung M; Ferris R; Kao J; Wang LH; Pan PY; Ko EC; Chen SH
Clin Cancer Res; 2015 Sep; 21(18):4073-4085. PubMed ID: 25922428
[TBL] [Abstract][Full Text] [Related]
43. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis.
Moeller A; Gilpin SE; Ask K; Cox G; Cook D; Gauldie J; Margetts PJ; Farkas L; Dobranowski J; Boylan C; O'Byrne PM; Strieter RM; Kolb M
Am J Respir Crit Care Med; 2009 Apr; 179(7):588-94. PubMed ID: 19151190
[TBL] [Abstract][Full Text] [Related]
44. Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis.
Cha SI; Chang CS; Kim EK; Lee JW; Matthay MA; Golden JA; Elicker BM; Jones K; Collard HR; Wolters PJ
Histopathology; 2012 Jul; 61(1):98-106. PubMed ID: 22394225
[TBL] [Abstract][Full Text] [Related]
45. Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.
Yoon JH; Nouraie M; Chen X; Zou RH; Sellares J; Veraldi KL; Chiarchiaro J; Lindell K; Wilson DO; Kaminski N; Burns T; Trejo Bittar H; Yousem S; Gibson K; Kass DJ
Respir Res; 2018 Oct; 19(1):195. PubMed ID: 30285867
[TBL] [Abstract][Full Text] [Related]
46. Investigation of key autophagy-and mitophagy-related proteins and gene expression in BALF cells from patients with IPF and RA-ILD.
Vasarmidi E; Sarantoulaki S; Trachalaki A; Margaritopoulos G; Bibaki E; Spandidos DA; Tzanakis N; Antoniou K
Mol Med Rep; 2018 Oct; 18(4):3891-3897. PubMed ID: 30106100
[TBL] [Abstract][Full Text] [Related]
47. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.
Salisbury ML; Xia M; Murray S; Bartholmai BJ; Kazerooni EA; Meldrum CA; Martinez FJ; Flaherty KR
Respir Med; 2016 Sep; 118():88-95. PubMed ID: 27578476
[TBL] [Abstract][Full Text] [Related]
48. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
[TBL] [Abstract][Full Text] [Related]
49. Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis.
Heukels P; van Hulst JAC; van Nimwegen M; Boorsma CE; Melgert BN; von der Thusen JH; van den Blink B; Hoek RAS; Miedema JR; Neys SFH; Corneth OBJ; Hendriks RW; Wijsenbeek MS; Kool M
Respir Res; 2019 Oct; 20(1):232. PubMed ID: 31651327
[TBL] [Abstract][Full Text] [Related]
50. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
51. C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.
Vuga LJ; Tedrow JR; Pandit KV; Tan J; Kass DJ; Xue J; Chandra D; Leader JK; Gibson KF; Kaminski N; Sciurba FC; Duncan SR
Am J Respir Crit Care Med; 2014 Apr; 189(8):966-74. PubMed ID: 24628285
[TBL] [Abstract][Full Text] [Related]
52. Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosis.
Smadja DM; Mauge L; Nunes H; d'Audigier C; Juvin K; Borie R; Carton Z; Bertil S; Blanchard A; Crestani B; Valeyre D; Gaussem P; Israel-Biet D
Angiogenesis; 2013 Jan; 16(1):147-57. PubMed ID: 22983452
[TBL] [Abstract][Full Text] [Related]
53. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.
Idorn M; Køllgaard T; Kongsted P; Sengeløv L; Thor Straten P
Cancer Immunol Immunother; 2014 Nov; 63(11):1177-87. PubMed ID: 25085000
[TBL] [Abstract][Full Text] [Related]
54. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
[TBL] [Abstract][Full Text] [Related]
55. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.
Rosas IO; Richards TJ; Konishi K; Zhang Y; Gibson K; Lokshin AE; Lindell KO; Cisneros J; Macdonald SD; Pardo A; Sciurba F; Dauber J; Selman M; Gochuico BR; Kaminski N
PLoS Med; 2008 Apr; 5(4):e93. PubMed ID: 18447576
[TBL] [Abstract][Full Text] [Related]
56. Detection of Circulating and Tissue Myeloid-Derived Suppressor Cells (MDSC) by Flow Cytometry.
Sanchez-Pino MD
Methods Mol Biol; 2022; 2422():247-261. PubMed ID: 34859411
[TBL] [Abstract][Full Text] [Related]
57. Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy.
Ornstein MC; Diaz-Montero CM; Rayman P; Elson P; Haywood S; Finke JH; Kim JS; Pavicic PG; Lamenza M; Devonshire S; Dann P; Schach K; Stephenson A; Campbell S; Emamekhoo H; Ernstoff MS; Hoimes CJ; Gilligan TD; Rini BI; Garcia JA; Grivas P
Urol Oncol; 2018 Sep; 36(9):405-412. PubMed ID: 29606341
[TBL] [Abstract][Full Text] [Related]
58. Idiopathic pulmonary fibrosis is associated with circulating antiepithelial antibodies.
Fahim A; Chong MC; Crooks MG; Hart SP
Lung; 2012 Aug; 190(4):451-8. PubMed ID: 22584870
[TBL] [Abstract][Full Text] [Related]
59. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
[TBL] [Abstract][Full Text] [Related]
60. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
Ghebremariam YT; Cooke JP; Gerhart W; Griego C; Brower JB; Doyle-Eisele M; Moeller BC; Zhou Q; Ho L; de Andrade J; Raghu G; Peterson L; Rivera A; Rosen GD
J Transl Med; 2015 Aug; 13():249. PubMed ID: 26231702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
